{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:06:38Z","timestamp":1791471998943,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science and Technology Major Special Project-Major New Drug Creation","award":["2019ZX09301-112"],"award-info":[{"award-number":["2019ZX09301-112"]}]},{"name":"Shandong Provincial Program of Taishan Industrial Experts","award":["No. TSCY 20190331"],"award-info":[{"award-number":["No. TSCY 20190331"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastoma is a lethal neoplasm with few effective therapy options. As a mainstay in the current treatment of glioma at present, chemotherapeutic agents usually show inadequate therapeutic efficiency due to their low blood brain barrier traversal and brain targeting, together with tumor multidrug resistance. Novel treatment strategies are thus urgently needed to improve chemotherapy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we report that nanomedicines developed by functionalizing the neurotropic rabies virus-derived polypeptide, RVG, and loading reduction-sensitive nanomicelles (polymer and doxorubicin) enable a highly specific and efficacious drug accumulation in the brain. Interestingly, curcumin serves as the hydrophobic core of the polymer, while suppressing the major efflux proteins in doxorubicin-resistant glioma cells. Studies on doxorubicin-resistant rat glioma cells demonstrate that the RVG-modified micelles exhibit superior cell entry and antitumor activity. In vivo research further showed that RVG modified nanomicelles significantly enhanced brain accumulation and tumor inhibition rate in mice, leading to a higher survival rate with negligible systemic toxicity. Moreover, effective suppression of recurrence and pulmonary metastatic nodules were also determined after the RVG-modified nanomicelles treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The potential of RVG-modified nanomicelles for glioma was demonstrated. Brain accumulation was markedly enhanced after intravenous administration. This unique drug delivery nanoplatform to the brain provides a novel and powerful therapeutic strategy for the treatment of central nervous system disorders including glioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphic abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-021-00997-z","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T06:02:56Z","timestamp":1629525776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["RVG-functionalized reduction sensitive micelles for the effective accumulation of doxorubicin in brain"],"prefix":"10.1186","volume":"19","author":[{"given":"Jiangkang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3860-948X","authenticated-orcid":false,"given":"Guangxi","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,21]]},"reference":[{"issue":"7","key":"997_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","volume":"15","author":"M Lim","year":"2018","unstructured":"Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15(7):422\u201342. https:\/\/doi.org\/10.1038\/s41571-018-0003-5.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"997_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","volume":"14","author":"G Reifenberger","year":"2017","unstructured":"Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M. Advances in the molecular genetics of gliomas-implications for classification and therapy. Nat Rev Clin Oncol. 2017;14(7):434\u201352. https:\/\/doi.org\/10.1038\/nrclinonc.2016.204.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"997_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics 2020. CA Cancer J Clin. 2020;70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"997_CR4","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/anie.201411226","volume":"127","author":"X Wei","year":"2015","unstructured":"Wei X, Zhan C, Shen Q, Fu W, Xie C, Gao J, Peng C, Zheng P, Lu W. Peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery. Angew Chem Int Ed Engl. 2015;127(10):3194\u20133194. https:\/\/doi.org\/10.1002\/anie.201411226.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"997_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1021\/acsnano.8b03785","volume":"13","author":"DJ Lundy","year":"2019","unstructured":"Lundy DJ, Lee KJ, Peng IC, Hsu CH, Lin JH, Chen KH, Tien YW, Hsieh PCH. Inducing a transient increase in blood-brain barrier permeability for improved liposomal drug therapy of blioblastoma multiforme. ACS Nano. 2019;13(1):97\u2013113. https:\/\/doi.org\/10.1021\/acsnano.8b03785.","journal-title":"ACS Nano"},{"issue":"8","key":"997_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrn2175","volume":"8","author":"RK Jain","year":"2007","unstructured":"Jain RK, Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007;8(8):610\u201322. https:\/\/doi.org\/10.1038\/nrn2175.","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"997_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"issue":"3","key":"997_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrn2995","volume":"12","author":"EA Neuwelt","year":"2011","unstructured":"Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, Leybaert L, Molnar Z, O\u2019Donnell ME, Povlishock JT, Saunders NR, Sharp F, Stanimirovic D, Watts RJ, Drewes LR. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci. 2011;12(3):169\u201382. https:\/\/doi.org\/10.1038\/nrn2995.","journal-title":"Nat Rev Neurosci"},{"issue":"34","key":"997_CR9","doi-asserted-by":"publisher","first-page":"28458","DOI":"10.1021\/acsami.8b10426","volume":"10","author":"NS Rejinold","year":"2018","unstructured":"Rejinold NS, Yoo J, Jon S, Kim YC. Curcumin as a novel nanocarrier system for doxorubicin delivery to MDR cancer cells: in vitro and in vivo evaluation. ACS Appl Mater Interfaces. 2018;10(34):28458\u201370. https:\/\/doi.org\/10.1021\/acsami.8b10426.","journal-title":"ACS Appl Mater Interfaces"},{"key":"997_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.addr.2018.07.002","volume":"132","author":"P Davoodi","year":"2018","unstructured":"Davoodi P, Lee LY, Xu Q, Sunil V, Sun Y, Soh S, Wang CH. Drug delivery systems for programmed and on-demand release. Adv Drug Deliv Rev. 2018;132:104\u201338. https:\/\/doi.org\/10.1016\/j.addr.2018.07.002.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"997_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nrd4333","volume":"13","author":"PV Torchilin","year":"2014","unstructured":"Torchilin PV. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov. 2014;13(11):813\u201327. https:\/\/doi.org\/10.1038\/nrd4333.","journal-title":"Nat Rev Drug Discov"},{"key":"997_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jconrel.2016.01.054","volume":"225","author":"C Bastiancich","year":"2016","unstructured":"Bastiancich C, Vanvarenberg K, Ucakar B, Pitorre M, Bastiat G, Lagarce F, Pr\u00e9at V, Danhier F. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma. J Control Release. 2016;225:283\u201393. https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.054.","journal-title":"J Control Release"},{"issue":"51","key":"997_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201803717","volume":"30","author":"Y Zou","year":"2018","unstructured":"Zou Y, Liu Y, Yang Z, Zhang D, Lu Y, Zheng M, Xue X, Geng J, Chung R, Shi B. Effective and targeted human orthotopic glioblastoma xenograft therapy via a multifunctional biomimetic nanomedicine. Adv Mater. 2018;30(51): e1803717. https:\/\/doi.org\/10.1002\/adma.201803717.","journal-title":"Adv Mater"},{"issue":"38","key":"997_CR14","doi-asserted-by":"publisher","first-page":"21589","DOI":"10.1021\/acsami.5b07045","volume":"7","author":"J Li","year":"2015","unstructured":"Li J, Yang H, Zhang Y, Jiang X, Guo Y, An S, Ma H, He X, Jiang C. Choline derivate-modified doxorubicin loaded micelle for glioma therapy. ACS Appl Mater Interfaces. 2015;7(38):21589\u2013601. https:\/\/doi.org\/10.1021\/acsami.5b07045.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"30","key":"997_CR15","doi-asserted-by":"publisher","first-page":"201701911","DOI":"10.1073\/pnas.1701911114","volume":"114","author":"Y Dou","year":"2017","unstructured":"Dou Y, Khan OF, Suv\u00e0 ML, Dong B, Lesniak MS. Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression. Proc Natl Acad Sci U S A. 2017;114(30):201701911. https:\/\/doi.org\/10.1073\/pnas.1701911114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"997_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2015.12.006","volume":"222","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Ren W, Zhong T, Zhang S, Huang D, Guo Y, Yao X, Wang C, Zhang WQ, Zhang X, Zhang Q. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity. J Control Release. 2016;222:56\u201366. https:\/\/doi.org\/10.1016\/j.jconrel.2015.12.006.","journal-title":"J Control Release"},{"issue":"4","key":"997_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1695","volume":"13","author":"X Zhou","year":"2021","unstructured":"Zhou X, Smith QR, Liu X. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13(4): e1695. https:\/\/doi.org\/10.1002\/wnan.1695.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"997_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jconrel.2019.07.020","volume":"309","author":"J Xu","year":"2019","unstructured":"Xu J, Khan AR, Fu M, Wang R, Ji J, Zhai G. Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs. J Control Release. 2019;309:106\u201324. https:\/\/doi.org\/10.1016\/j.jconrel.2019.07.020.","journal-title":"J Control Release"},{"issue":"Pt A","key":"997_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2015.10.013","volume":"220","author":"RL Cook","year":"2015","unstructured":"Cook RL, Householder KT, Chung EP, Prakapenka AV, DiPerna DM, Sirianni RW. A critical evaluation of drug delivery from ligand modified nanoparticles: confounding small molecule distribution and efficacy in the central nervous system. J Control Release. 2015;220(Pt A):89\u201397. https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.013.","journal-title":"J Control Release"},{"issue":"1","key":"997_CR20","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1038\/s41467-018-04910-5","volume":"9","author":"G Zhang","year":"2018","unstructured":"Zhang G, Li X, Liao Q, Liu Y, Xi K, Huang W, Jia X. Water-dispersible PEG-curcumin\/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug delivery. Nat Commun. 2018;9(1):2785. https:\/\/doi.org\/10.1038\/s41467-018-04910-5.","journal-title":"Nat Commun"},{"key":"997_CR21","doi-asserted-by":"publisher","DOI":"10.1039\/d0bm01536a","author":"H Zhang","year":"2021","unstructured":"Zhang H, Van Os WL, Tian X, Zu G, Ribovski L, Bron R, Bussmann J, Kros A, Liu Y, Zuhorn IS. Development of curcumin-loaded zein nanoparticles for transport across the blood-brain barrier and inhibition of glioblastoma cell growth. Biomater Sci. 2021. https:\/\/doi.org\/10.1039\/d0bm01536a.","journal-title":"Biomater Sci"},{"key":"997_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/IJN.S275938","volume":"16","author":"S Li","year":"2021","unstructured":"Li S, Yang S, Liu C, He J, Li T, Fu C, Meng X, Shao H. Enhanced photothermal-photodynamic therapy by indocyanine green and curcumin-loaded layered MoS2 hollow spheres via inhibition of p-glycoprotein. Int J Nanomed. 2021;16:433\u201342. https:\/\/doi.org\/10.2147\/IJN.S275938.","journal-title":"Int J Nanomed"},{"key":"997_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108553","volume":"88","author":"H Kaur","year":"2021","unstructured":"Kaur H, Moreau R. Curcumin steers THP-1 cells under LPS and mTORC1 challenges toward phenotypically resting, low cytokine-producing macrophages. J Nutr Biochem. 2021;88: 108553. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108553.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"997_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13046-018-0792-5","volume":"37","author":"S Mukherjee","year":"2018","unstructured":"Mukherjee S, Fried A, Hussaini R, White R, Baidoo J, Yalamanchi S, Banerjee P. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia\/macrophages and elimination of GBM and GBM stem cells. J Exp Clin Cancer Res. 2018;37(1):168. https:\/\/doi.org\/10.1186\/s13046-018-0792-5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"997_CR25","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1002\/ijc.30398","volume":"139","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee S, Baidoo J, Fried A, Atwi D, Dolai S, Boockvar J, Symons M, Ruggieri R, Raja K, Banerjee P. Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma. Int J Cancer. 2016;139(12):2838\u201349. https:\/\/doi.org\/10.1002\/ijc.30398.","journal-title":"Int J Cancer"},{"issue":"1","key":"997_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00441-019-03127-2","volume":"379","author":"AY Tsidulko","year":"2020","unstructured":"Tsidulko AY, Kazanskaya GM, Volkov AM, Suhovskih AV, Kiselev RS, Kobozev VV, Gaytan AS, Krivoshapkin AL, Aidagulova SV, Grigorieva EV. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis. Cell Tissue Res. 2020;379(1):147\u201355. https:\/\/doi.org\/10.1007\/s00441-019-03127-2.","journal-title":"Cell Tissue Res"},{"key":"997_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.115837","volume":"233","author":"AR Khan","year":"2020","unstructured":"Khan AR, Yang X, Du X, Yang H, Liu Y, Khan AQ, Zhai G. Chondroitin sulfate derived theranostic and therapeutic nanocarriers for tumor-targeted drug delivery. Carbohydr Polym. 2020;233: 115837. https:\/\/doi.org\/10.1016\/j.carbpol.2020.115837.","journal-title":"Carbohydr Polym"},{"issue":"8","key":"997_CR28","doi-asserted-by":"publisher","first-page":"9386","DOI":"10.1021\/acsnano.9b04166","volume":"13","author":"H Li","year":"2019","unstructured":"Li H, Zhang P, Luo J, Hu D, Huang Y, Zhang ZR, Fu Y, Gong T. Chondroitin sulfate-linked prodrug nanoparticles target the golgi apparatus for cancer metastasis treatment. ACS Nano. 2019;13(8):9386\u201396. https:\/\/doi.org\/10.1021\/acsnano.9b04166.","journal-title":"ACS Nano"},{"issue":"48","key":"997_CR29","doi-asserted-by":"publisher","first-page":"25463","DOI":"10.1039\/C2JM35420A","volume":"22","author":"SA Krovi","year":"2012","unstructured":"Krovi SA, Swindell EP, O\u2019Halloran TV, Nguyen ST. Improved anti-proliferative effect of doxorubicin-containing polymer nanoparticles upon surface modification with cationic groups. J Mater Chem. 2012;22(48):25463\u201370. https:\/\/doi.org\/10.1039\/C2JM35420A.","journal-title":"J Mater Chem"},{"issue":"19","key":"997_CR30","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1016\/j.biomaterials.2014.03.027","volume":"35","author":"L Li","year":"2014","unstructured":"Li L, Yang Q, Zhou Z, Zhong J, Huang Y. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting. Biomaterials. 2014;35(19):5171\u201387. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.03.027.","journal-title":"Biomaterials"},{"key":"997_CR31","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jconrel.2020.05.005","volume":"323","author":"A Mozhi","year":"2020","unstructured":"Mozhi A, Sunil V, Zhan W, Ghode PB, Thakor NV, Wang CH. Enhanced penetration of pro-apoptotic and anti-angiogenic micellar nanoprobe in 3D multicellular spheroids for chemophototherapy. J Control Release. 2020;323:502\u201318. https:\/\/doi.org\/10.1016\/j.jconrel.2020.05.005.","journal-title":"J Control Release"},{"issue":"11","key":"997_CR32","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754\u201362. https:\/\/doi.org\/10.1038\/nrc3829.","journal-title":"Nat Rev Cancer"},{"issue":"35","key":"997_CR33","doi-asserted-by":"publisher","first-page":"11334","DOI":"10.1002\/anie.201806466","volume":"57","author":"R Lizatovic","year":"2018","unstructured":"Lizatovic R, Assent M, Bearendregt A, Dahlin J, Bille A, Satzinger K, Tupina D, Heck AJR, Wennmalm S, Andre I. A protein-based encapsulation system with calcium-controlled cargo loading and detachment. Angew Chem Int Ed Engl. 2018;57(35):11334\u20138. https:\/\/doi.org\/10.1002\/anie.201806466.","journal-title":"Angew Chem Int Ed Engl"},{"key":"997_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117459","volume":"254","author":"X Shi","year":"2021","unstructured":"Shi X, Yang X, Liu M, Wang R, Qiu N, Liu Y, Yang H, Ji J, Zhai G. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer. Carbohydr Polym. 2021;254: 117459. https:\/\/doi.org\/10.1016\/j.carbpol.2020.117459.","journal-title":"Carbohydr Polym"},{"key":"997_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.msec.2018.07.001","volume":"92","author":"YB Sutar","year":"2018","unstructured":"Sutar YB, Telvekar VN. Chitosan based copolymer-drug conjugate and its protein targeted polyelectrolyte complex nanoparticles to enhance the efficiency and specificity of low potency anticancer agent. Mater Sci Eng C Mater Biol Appl. 2018;92:393\u2013406. https:\/\/doi.org\/10.1016\/j.msec.2018.07.001.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"997_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jconrel.2018.10.007","volume":"290","author":"M Liu","year":"2018","unstructured":"Liu M, Khan AR, Ji J, Lin G, Zhao X, Zhai G. Crosslinked self-assembled nanoparticles for chemo-sonodynamic combination therapy favoring antitumor, antimetastasis management and immune responses. J Control Release. 2018;290:150\u201364. https:\/\/doi.org\/10.1016\/j.jconrel.2018.10.007.","journal-title":"J Control Release"},{"issue":"1","key":"997_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ijpharm.2017.03.065","volume":"523","author":"H Du","year":"2017","unstructured":"Du H, Liu M, Yu A, Ji J, Zhai G. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin. Int J Pharm. 2017;523(1):427\u201338. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.065.","journal-title":"Int J Pharm"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-00997-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-021-00997-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-00997-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T06:07:44Z","timestamp":1629526064000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-021-00997-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,21]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1186\/s12951-021-00997-z","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,21]]},"assertion":[{"value":"19 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed in accordance with the Regulations of the People\u2019s Republic of China on the Management of Laboratory Animals (2017) and approved by the Ethics Committee of Shandong University Animal Laboratory.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest in the paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}